Literature DB >> 2071789

Retrospective analysis of the incidence of pulmonary disease in hypogammaglobulinemia.

S K Sweinberg1, R A Wodell, M P Grodofsky, J M Greene, M E Conley.   

Abstract

To determine the best predictors of chronic pulmonary disease in patients with hypogammaglobulinemia, we evaluated the clinical records, chest x-ray films, and pulmonary function tests of 10 patients with X-linked agammaglobulinemia (XLA) followed for a mean of 12.5 years, and 12 patients with common variable immunodeficiency (CVID) followed for a mean of 10.5 years. These patients, most of whom were treated with intramuscular gamma globulin and long-term oral antibiotics, had very few pneumonias after diagnosis. The patients with XLA had 0.10 pneumonias per treatment year, and the patients with CVID had 0.18 pneumonias per treatment year. Seven of the 10 patients with XLA had normal chest x-ray films 8 to 15 years after diagnosis, and none had bronchiectasis. Pulmonary disease was more common and more severe in the group with CVID, but five patients in this group also had normal chest x-ray films after long follow-up. In the entire group of 22 patients, nine of the 10 patients with abnormal chest x-ray films on most recent evaluation already had pulmonary disease at the initial visit (p = 0.00002). These studies indicate that the best predictors of good pulmonary function in patients with hypogammaglobulinemia are early diagnosis and good compliance with gamma globulin replacement therapy and oral antibiotics.

Entities:  

Mesh:

Year:  1991        PMID: 2071789     DOI: 10.1016/0091-6749(91)90306-9

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  23 in total

Review 1.  X-linked agammaglobulinemia.

Authors:  M E Conley; J Rohrer; Y Minegishi
Journal:  Clin Rev Allergy Immunol       Date:  2000-10       Impact factor: 8.667

2.  Airway and interstitial lung disease are distinct entities in paediatric common variable immunodeficiency.

Authors:  A A J M van de Ven; P A de Jong; D P Hoytema van Konijnenburg; O A M Kessels; M Boes; E A M Sanders; S W J Terheggen-Lagro; J M van Montfrans
Journal:  Clin Exp Immunol       Date:  2011-06-02       Impact factor: 4.330

Review 3.  Common variable immune deficiency: reviews, continued puzzles, and a new registry.

Authors:  Charlotte Cunningham-Rundles; Adina Kay Knight
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

4.  Serial lung function tests in primary immune deficiency.

Authors:  A L Rich; I R Le Jeune; L McDermott; W J M Kinnear
Journal:  Clin Exp Immunol       Date:  2007-11-14       Impact factor: 4.330

Review 5.  Immune Gamma Globulin Therapeutic Indications in Immune Deficiency and Autoimmunity.

Authors:  Luanna Yang; Eveline Y Wu; Teresa K Tarrant
Journal:  Curr Allergy Asthma Rep       Date:  2016-07       Impact factor: 4.806

6.  Effectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: results from a multicenter prospective cohort study.

Authors:  Isabella Quinti; Annarosa Soresina; Andrea Guerra; Roberto Rondelli; Giuseppe Spadaro; Carlo Agostini; Cinzia Milito; Amelia Chiara Trombetta; Marcella Visentini; Helene Martini; Alessandro Plebani; Massimo Fiorilli
Journal:  J Clin Immunol       Date:  2011-03-02       Impact factor: 8.317

Review 7.  Clinical immunology in practice, new opportunities.

Authors:  Mark R Stein
Journal:  Clin Rev Allergy Immunol       Date:  2004-10       Impact factor: 8.667

8.  Pulmonary and sinus diseases in primary humoral immunodeficiencies with chronic productive cough.

Authors:  F Rusconi; C Panisi; R M Dellepiane; F Cardinale; L Chini; B Martire; N Bonelli; G Felisati; M C Pietrogrande
Journal:  Arch Dis Child       Date:  2003-12       Impact factor: 3.791

Review 9.  Common variable immunodeficiency: etiological and treatment issues.

Authors:  Sean Deane; Carlo Selmi; Stanley M Naguwa; Suzanne S Teuber; M Eric Gershwin
Journal:  Int Arch Allergy Immunol       Date:  2009-07-01       Impact factor: 2.749

Review 10.  Recognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic review.

Authors:  P Wood; S Stanworth; J Burton; A Jones; D G Peckham; T Green; C Hyde; H Chapel
Journal:  Clin Exp Immunol       Date:  2007-06-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.